Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Fig. 2

Treatment-specific HLA haplotypes. a, b The association of nADA titers for selected extended haplotypes showing strong treatment-specific effects. For association statistics, see Table 5 and Additional file 22. Disc. = discovery, Repl. = replication. a The association of the DR15-DQ6 haplotype with nADA titers is specific for IFNβ-1a s.c. b The association of the DR4-DQ3 haplotype with nADA titers is specific for IFNβ-1b s.c

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us